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Another French case of nephropathy with familial lecithin cholesterol
acyl transferase (LCAT) deficiency. P. Bones, D. Adoue, M. L. Solera,
J. de Graeve, M. Lebot, A. Segonds, P. Bec, andf. M. Suc, Service de
Nephrologie and INSERM U-133, CHU Rangueil, Toulouse, France.
A 31-year-old woman, born in central France (Cantal), was admitted for
proteinuria that was first discovered 4 years earlier. Two years before
this discovery, the patient had an uncomplicated pregnancy. During
hospitalization, proteinuria was 1 g/24 hr, renal function was normal,
and there was a mild anemia: hemoglobin 11.5 g/dl with moderate
reticulocytosis. The renal biopsy showed mesangial, subendothelia!,
and membranous amorphous deposits and foam cells in the glomeruli,
interstitium, and arterioles. Based on corneal opacity, with normal
visual function, a familial LCAT deficiency was considered and con-
firmed by the study of lipid metabolism, which showed low cholesterol
ester (0.5 mM) and low cholesterol ester/total cholesterol ratio 12%(normal 60% to 80%). LCAT activity measured by the Stokke and
Norum method was very low: esterification rate per hr 0.95% (normal
5.3 1.1) and molar rate (moles/liter/hr of cholesterol esterified);
8.37—normal 63 16 in our hands. Other abnormalities already
described in LCAT deficiency were also present, including an absence
of lipoproteins on electrophoresis (because of the abnormal structure of
HDL), low Apo A concentration. The familial study was limited by
poor cooperation, but it did allow us to examine a sister of this patient,
47-years-old, with corneal opacity and LCAT deficiency whose choles-
terol ester was less than 0.1 mi, esterification rate (0.83%), and molar
rate 71 moles/liter/hr of cholesterol esterified. This second patient had
no proteinuria. Familial LCAT deficiency is a rare disease with a
proteinuria associated with storage nephropathy, renal failure appear-
ing during adult life, corneal opacity, and hemolytic anemia. Most of the
cases were described by Scandinavian authors. To the best of our
knowledge, our study is the third-reported case in France and the 23rd
case known in the world.
Pharmacokinetic studies on high dose furosemide in CAPD. H. F.
Boutron, J. F. Brocard, E. Singlas, B. Charpentier, and D. Fries.
Laboratoire de Pharmacocinerique, Hopital de Bicétre, Service de
Nephrologie, Hôpital Paul Brousse, Faculté de Médecine Paris,
France. We have previously shown that hemodialysis does not remove
enough furosemide (F) to require dosage adjustment to ensure adequate
blood levels. In view of the wide usage of high doses of F in CAPD-
treated patients, we have studied the pharmacokinetics of the diuretic in
7 adult patients: CAPD had been used for at least 3 months, 3 bag
(Travenol) exchanges were performed per day and creatinine clearance
was 3.1 0.9 mI/mm. After an F oral dose of 500 mg, the peak of
plasma concentration was obtained at the sixth hr (2 to 12), with a mean
value of 13.00 3.05 g/ml (7.50—26.00 g/ml). Plasma half-life was 10.2
1.5 hr. The amount ofF extracted in the peritoneum was less than 1% of
the initial dose. The peritoneal clearance was 0.45 0.08 mI/mm. Five
% of the F was eliminated by the kidney, and the F renal clearance was
2.80 0.95 mI/nun. Two patients were studied before and after a
peritonitis episode. The pharmacokinetics of F was not modified by the
infection. The amount of F extracted was 0.5% and 0.8% of the initial
dosage, and the peritoneal clearances were 0.25 and 0.45 mI/mm,
respectively. No correlations were found either between the F plasma
concentration and diuresis, or between F renal or peritoneal clearance
and creatinine clearance.
Survival of elderly patients with acute renal failure (ARF). F. Brivet,
A. Blanchi, J. F. Delfraissy, J. Dormont. Intensive care unit, A. Beclere
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Hospital, Clamart, France. The lack of improvement in survival
patients with ARF, in spite of remarkable advances in intensive care
medicine, may be due to an increased frequency of septic ARF and/or
the association with multiple organ dysfunction. The role of age as a
risk factor is a matter of controversy. To evaluate this role, we have
reviewed the final outcome in 50 ARF patients aged 65 or older (74.6
5.6, mean SD), treated between 1978 and 1980 with hemodialysis one
or more times. Thirty patients (60%) died during the period of ARF,
while 6 died 15 to 180 days following the recovery of renal function. The
prognosis was poor in patients with ARF due to surgical causes (16
cases, 81% mortality), with sepsis preceding or occurring during ARF
(22 patients, 95% mortality), in patients requiring mechanical ventila-
tion (28 patients, 85% mortality), and in patients with shock (35
patients, 80% mortality). The outcome was independent of the persis-
tence of urine flow, mortality was 66% in 36 anuric cases and 42% in 14
nonoliguric cases. The mortality in elderly patients with ARF treated by
hemodialysis is thus similar to that observed in the large published ARF
series, irrespective of age. It can be concluded that a patient's age does
not appreciably affect the prognosis of ARF.
Lectin-induced lymphocyte cytotoxicity in systemic lupus erythemato-
sus (SLE). B. Charpentier, P. Lang, B. Martin, andD. Fries. Service de
Néphrologie, Hôpital Paul Brousse, Villejuif, France. SLE is an
autoimmune disease which has been reported to show evidence of
cellular abnormalities. Defects in regulatory T cells and cytotoxic T
cells were postulated to play a central role in the pathogenesis of the
disease. We have previously shown in an in vitro model of xenogeneic
sensitization that generation of cytotoxic T cells against mouse lym-
phoid cells was drastically impaired in a panel of 17 patients with SLE.
In order to investigate other cytotoxic cell functions, we used phytohae-
magglutinin-induced lymphocyte cytotoxicity (LDCC) in our xenogene-
ic system. Peripheral blood lymphocytes (PBL) from 11 patients with
SLE were assayed as effector cells against 51Cr-labelled P815 (H2d) or
EL4 (H2b) mouse cells. Fresh or cultured PBL showed a normal
cytotoxic response compared to controls. All SLE patients disclosed a
normal cytolytic response regarding disease activity, drug therapy, and
other immunological parameters such as antibodies against native
DNA, complement levels, cryoglobulinemia, circulating immune com-
plexes or T and B cell numbers. Moreover, the addition of PHA to the
in vitro educated lymphocytes during the cytolytic assay markedly
restored their lytic capacity. In conclusion PBL of SLE patients show
evidence of a specific defect of cytolysis after in vitro sensitization
although non specific lysis such as LDCC is not dramatically impaired.
This abnormality could be restored by a "non-specific" ligand such as
PHA, which could act as an "extra-bridge" between effectors and
targets and allowing the delivery of the "lethal hit."
Cortinarius Splendens intoxication and acute renal failure: A cinico-
pathological study. S. Colon, P. Deteix, M. Bénuard, A. Gérault, A.
Finaz, P. Zech, and J. Traeger. Clinique de néphrologie et des
maladies métaboliques, INSERM U-80, Hôpital E. Herriot, Lyon,
Clinique do Tonkin, Unite de Néphrologie, Villeurbanne, and HIA
Desgenettes, Bron, France. Acute renal failure after intoxication with
some types of cortinarius was first reported 28 years ago. We described
5 cases with histopathologic studies after a family intoxication involving
17 patients. It was the first observation of Cortinanius Splendens
toxicity. The outcome was satisfactory in 3 patients; 1 died with
intracerebral hematoma, and 1 is dialyzed for chronic renal failure.
Pathologic studies revealed tubulointerstitial nephritis in these 5 cases
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whereas there was no glomerular injury. Tubular lesions suggested
direct, cellular toxicity, but some histologic patterns gave support to the
hypothesis of an allergic mechanism.
Uremic middle molecules and glucose metabolism. A. Crevat, M.
Hassid, N. Fournier, P. Ga/lice, J. C. Sari, A. Murisasco, R. Frays-
sinet, and S. Saingra. Laboratoire de Biophysique et Service de
Néphrologie, Facu/té de Médecine, Marseille, France. Glucose intoler-
ance is often seen in chronic renal disease treated by hemodialysis. In
addition, uremic serum contains a factor inhibiting glucose utilization.
In view of this, we tested the action of middle molecules on the
phosphorylation of glucose to glucose-6-phosphate. Uremic middle
molecules (UMM) were extracted from plasma ultrafiltrate of uremic
patients by gel permeation (using a modification of Furst's technique).
The action of middle molecules was tested on the reaction: Glucose +
ATP Hexokinase + Mg2—*/"H glucose-6-phosphate + ADP. The
rate of reaction was determined by measuring the acidification of the
medium by potentiometric titration at constant pH. We determined the
Michaelis curve v initial = f (ATP Mg) with and without UMM (0.5
103M). We observed that the rate of reaction was reduced in the
presence of middle molecules. The Lineweaver-Burk transformation 1/
v = f(l/ATP Mg) indicates that there is no competitive inhibition of the
enzyme by UMM.
Effect of cimetidine on plasma levels of parathyroid hormone (PTH)
and calcitonin (CT) in uremia. P. H. Decourcelle, P. Morinière, J.
Guéris, C. Calmettes, P. Bataille, P. Fievet, J. D. Gheerbrandt, R.
Makdassi, B. Coevoet, and A. Fournier. CHU Amiens, Hôpital Lan-
boisière, INSERM U-113, Paris, France. The effectiveness of cimeti-
dine in suppressing hyperparathyroidism in uremia is controversial.
Contradictory results may be explained by differences in dosages,
compliance, and PTH assays. We, therefore, measured plasma concen-
trations (P) of PTH by C and N terminal assays, simultaneously with
those of CT, 25 OH vitamin D, calcium, phosphate, alkaline phospha-
tase, and cimetidine twice at 15-day intervals, before, during, and after
one month administration of cimetidine (400 mg/d) in 11 patients on
chronic dialysis. During the whole period, dialysis strategy, CaCO3 and
Al(OH)3 doses were kept constant. None of the patients received
vitamin D. P cimetidine was never detectable in 4 patients, suggesting
non-compliance. Their P PTH an&CT did not change significantly. In
the other 7 patients who were given P cimetidine in the usual therapeu-
tic range (0.40 to 5.85 1ig/ml), no significant variation of P PTH was
observed in these patients with either one of the assays. P CT decreased
significantly in all patients except 1 where it was undetectable. The
mean decrease was 75 25% after 15 and 30 days. After cimetidine
discontinuation, P CT increased to initial values. No significant change
in other parameters was observed in either group, except PCa which
decreased by 5% (P < .05) at 30 days, which may explain the non-
suppression of PTH. In conclusion, at usual therapeutic levels of P
cimetidine, secretion of CT but not that of PTH is suppressed in uremia.
This finding does not warrant the use of cimetidine in the treatment of
osteitis fibrosa in uremia.
Hemofiltration does not worsen or improve hyperparathyroidism. J. F.
de Fremont, P. Morinière, P. H. Decourcelle, M. C. Mercier, J. Gueris,
J. D. Gheerbrandt, R. Makdassi, and A. Fournier. CHU Amiens and
Hôpital Lariboisière, Paris, France. Hemofiltration (HF) has been
claimed to improve or worsen hyperparathyroidism (H). This contradic-
tion may be explained by differences in vitamin D (D) supplementation
and in calcium (Ca) balance during a HF procedure. Our study
describes the usage of Ca concentration in the substitution fluid (SF Ca)
modulated at each run according to the desired wt loss in order to
produce a positive Ca balance of 200 mg per procedure (mean SF Ca #
9.4 mg/dl). A constant dose of Al(OH)3 (6 2 g/d) and CaCO3 (3 g/d) was
also given. Serial quarterly measurements of plasma concentration (P)
of Ca, phosphate, alkaline phosphatases (AP), PTH (N and C terminal
assays), and 25 OH D were made for 9 to 42 months in 12 patients. In 7
patients who initially had no radiological bone disease (RBD), normal
AP and who did not take a D supplement, there was no significant
change in either parameter measured. In the 5 other patients who
initially had severe RBD and increased AP in spite of previous
treatment by D nietabolites, HF was performed in the hope of improv-
ing HP. After 6 to 34 months, surgical parathyroidectomy was finally
performed in all patients because of lack of improvement. Three months
later, AP and N terminal PTH normalized and in the 3 patient
maintained on HF, remained so for 12 to 30 months, except in I patient
whose hypocalcemia was not corrected by I to 25 (OH)2D3. In
conclusion, HF per se does not worsen or improve HP; a positive
calcium balance of 200 mg per procedure seems essential to prevent HP
worsening; and vitamin D supplement is essential in PTX patients to
maintain normal PCa and P PTH.
Control of hyperparathyroidism by continuous ambulatory peritoneal
dialysis (CAPD). J. F. de Fremont, P. Morinière, P. H. Decourcelle, A.
Roussel, R. Makdassi, P. Kaczmareck, P. Fievet, P. Bataille, andA.
Fournier. CHU Amiens, France. Hyperparathyroidism has been re-
ported to be worsened by CAPD with a dialysate calcium (DCa) of 6.0
mgldl which induced a negative peritoneal Ca balance, in spite of the
prevention of vitamin D(D) depletion. Our study describes the usage of
a DCa of 7.0 mg/dl inducing a positive Ca balance of 169 44mg/day
for ionized Ca. No vitamin D supplement was given. CaCO3 oral
supplement was fixed at 3 g/day and Al(OH)3 was discontinued.
Eighteen patients were treated for 6 months. Their plasma (P)Ca and
PU4 remained constant respectively at (mean saM) 8.8 I and 4.5 2
mg/dl. P protein decreased from 6.6 to 6.1 g/dl (P < 0.05). Alkaline
phosphatase decreased from 140 10 to 108 7 IU (P < .05). P PTH
decreased from 182 27 to 116 30 ng/ml with the C Terminal assay (P
< .05) and from 0.13 0.02 to 0.08 0.2 ng/ml (P < .05) with the N
Terminal assay. In the 5 patients treated for 12 months, the decrease
was more profound. P 25 OH D decreased significantly from 24 9 to
10 3 ng/ml at 6 and 12 months with P < .01 (normal range 15 to 80 ng/
ml). A significant change was not observed in the radiological survey. A
study of individual data showed that the only 3 patients who increased P
PTH were those who had a significant decrease in plasma calcium, most
likely explained by a greater D depletion (83% vs. 48% decrease of P 25
OH D3). In conclusion, a positive balance of peritoneal calcium and
CaCO3 oral supplement allow suppression of hyperparathyroidism in
most cases, and the occurrence of severe D depletion justifies routine
vitamin D supplementation.
Sodium removal (N Na) as a function of ultrafiltration rate (QUF) and
dialysate sodium concentration ([NaJ0). S. di Giulio, A. Sausse, N. K.
Man, J. Crosnier, J. L. Funck-Brentano. Departernent de Nephrologie,
INSERM U-90, HOpital Necker, Paris, France. Hypotensive episodes
during hemodialysis are treated by injections of saline; muscle cramps
are generally treated by injections of hypertonic sodium solutions.
Symptoms are also prevented using high [NaID. These procedures
decrease the excessive sodium removal which generally occurs when
the interdialytic water load is removed. To obtain adequate [Na]0
preventing symptoms and accounting for the interaction between
convective transport (ultrafiltration) and diffuse transport (dialysis), we
used the following addition formula: (1) CIT = Cl0 + QUF — (ClDQUF/
QPI) where CIT = total clearance; Cl0 = diffusive clearance; QUF =
ultrafiltration rate; Q1 = inlet plasma flow rate. Total N Na is
calculated from the formula (2) N Na = ClTtd. [Nai where [Na] =Na plasma concentration. Total N Na is measured by the Na mass
increase in the dialysate. Four patients were treated with hemodialysis
routinely 3 times a week, 4 hours with [Na10 145 2 mmoles1iter
were studied during the first hour of 16 non-consecutive hemodialysis
sessions with QUF ranging between 2.58 and 65 mbmin, dialysate
flow of 250 50 mbmin, [Naj0 ranging between 144 and 191
mmoles1iter. The initial [Na] range was between l30 and 143
mmoles1iter1. No symptom occurred during the observation. There is
a linear relationship between N Na measured and N Na calculated
according to formulas (1) and (2): y = 1.074 x — 10.4; r = 0.984; N =
16. Formula (1) allows calculation of the adequate [NaJ0 resulting in
asymptomatic transfer of the Na and water interdialytic load.
Captopril and labetalol in refractory hypertension. A. el Main, M. S.
Larabi, A. Kheder, C. Be/kahia, H. Ben Maiz, and H. Ben Ayed.
Hôpital Charles Nicolle, TUNIS, TUNISIE, France. Fifteen patients
with malignant or severe refractory hypertension were treated with a
combination of captopril and labetalol. The hypertension was essential
in 6 cases, due to nephroangiosclerosis in 3 cases, to chronic pyelone-
phritis in 2 cases, to chronic glomerulonephritis in I case, and to
vasculitis in I case. The patients were divided into groups A and B; all
were on a free salt diet. The 7 patients in group A, receiving only 300
mg/day captopril, exhibited a mean arterial pressure (MAP) that de-
creased slightly from 162.7 20.5 to 151.6 172 mm Hg and proved to
be insignificant. The mean was SEM. But when labetalol was added,
the MAP decreased significantly (P < 0.05) to 117.4 21. Group B was
treated with labetalol alone with a dose of up to 1200 mg/day; MAP
Abstracts 123
decreased slightly from 163.5 24.9 to 142.6 16.9 (NS). When
captopril was added, the MAP decreased very significantly (P < 0.001)
to 102.4 15.1 mm Hg. No major side effect was noted except one case
of severe pancytopenia. In drug resistant hypertension, association of
the 2 drugs proved to be effective in all cases. Thus, the antihyperten-
sive potential of one drug is considerably enhanced when combined
with the other.
Glomerular lesions in a patient with bullous pemphigoid (BP). P.
Glasson, G. Pfister, D. Poffet, F. Chatelanat, and H. Favre. Depart-
ments of Medicine and Pathology, Hôpital Cantonal Universitaire,
Geneva, Switzerland. Bullous pemphigoid is characterized immunologi-
cally by deposition of C3, IgG, Clq, and properdin in the basement
membrane zone (BMZ) of the skin and by circulating autoantibodies
specific for BMZ of the skin. Those antibodies activate the classical
complement pathway. It is therefore logical to postulate that kidneys
may be involved in the course of the disease, but to our knowledge, this
observation has not yet been reported. A 75-year-old man was admitted
for bullous eruption of the skin. Light microscopy (LM) of a skin biopsy
revealed findings compatible with the diagnosis of BP. An immunofiuo-
rescent study (IF) revealed antibodies bound to the subepithelial zone
and C3, IgG, and fibnnogen deposit at the BMZ. Plasma creatinine was
to 178 moles/liter and creatinine clearance to 38 mI/mm. Proteinuria
was 2.7 g/d. Urine sediment revealed numerous erythrocytes without
casts. A renal biopsy exhibited C3 and fibnnogen deposit in the
mesangium at IF and multiple deposits appearing like humps in the
basal membrane and in the mesangium at LM. The patient was given
steroid treatment. Two weeks later, skin lesions had disappeared and
renal function returned to a normal level (Ce. = 70 mI/mm, proteinuria
1.1 g/d, normal urine sediment without erythrocytes). In conclusion,
glomerular lesions may occur in the course of BP. BP's mechanism
appears to be similar to skin lesions as judged by the similarity of LM
and IF. On steroid treatment, skin and renal lesions have a similar
favorable evolution.
Acute renal failure (ARF) revealing "minimal change" glomerular
lesions (MCGL) in adults. D. Hi/lion, J. P. Pignon, A. Bergue, G.
Dongradi, J. P. Fend/er. Poissy, France. The disease of a 65-year-old
woman began 8 days before admission to the hospital with oliguria and
edema. A diagnosis of ARF was made: Serum creatinine was 630 mol/
I, blood urea 40 mmol/l, natriuresis 6 mmolll, urinary urea 190 mmol/l,
with nephrotic syndrome. Total serum protein proved to be 5.5 g/dl,
serum albumin 2.5 g/dl, and proteinuria 0.5 g/dl without hematuria.
Blood pressure was 130 to 80 mm Hg. Persistent oliguria below 400 ml!
24 hr for 3 weeks required hemodialysis. Radiologic examination
showed enlarged kidneys and permeable renal veins; glomeruli were
optically normal, and immunofluorescence (IF) was negative. There
were normal tubules and interstitial edema. The ARF regressed (serum
creatinine 160 p.mol/l, diuresis 1000 ml/24 hr) when corticosteroid
therapy was started. Complete remission of ARF and nephrotic syn-
drome occurred after 6 weeks and persisted 3 months after treatment
was discontinued. Eighteen similar cases were reviewed. The patient
population comprised 8 females and 11 males whose mean age was 58
yrs (17 to 82). All showed oliguria and 9 hypertension; mean serum
albumin was 1.9 g/dl. All 21 renal biopsies, 18 of which with IF and/or
electron microscopy, showed MCGL. Seventeen patients received
corticosteroid therapy, begun in I case after a cure of ARF. It was
discontinued in 3 cases for lack of effect.
Nephrotic
Beginning of corticosteroid
Renal failure syndrome
—_______________
therapy
N Cure MHD
Persisting
Cure proteinuria
During ARF 13 11
3 2
2
1
10
1 1
After ARF 1 1 I
Except for ARF, these cases do not differ from other MCGL. ARF may
be accounted for by decreased glomerular capillary permeability,
hypovolemia and/or acute tubular necrosis due to massive proteinuria,
tubular obstruction by protein casts, intrarenal vasoconstriction, fall in
filtration fraction in normotensive patients because of increased hydro-
static pressure due to interstitial edema. Only the last two mechanisms
seem to be in question in our study.
Indications and results of subtotal parathyroidectomy on patients
suffering from chronic renal insufficieny. F. Maurice, P. Mathieu, M.
Kessler, and C. Huriet. Service de Nephrologie, CHU de Nancy,
France. Our study focuses on the indications and results of 52 subtotal
parathyroidectomies, performed on 47 patients suffering from chronic
renal failure who had undergone hemodialysis and transplantation. The
indications were based on clinical criteria: Pruritus, bone pain, sponta-
neous fracture, tendon rupture, associated hypercalcemia, hyperphos-
phatemia, and an increase in serum alkaline phosphatase level in spite
of suitable medical treatment. Bone scintigraphy aided in the diagnosis.
The serum immunoreactive measurement of parathyroid hormone is not
indispensable. No bone biopsy was performed. Parathyroidectomy is a
minor surgical operation which causes little trauma. The death rate
during the operation is nul, and post-operative treatment is simple.
During the operation 96% of the parathyroid glands were found. In
every case the operation consisted in a subtotal parathyroidectomy.
Wells's technique was used only for 2 re-operations. The benefits of the
operation were significant: Pruritus and bone pain were relieved;
general signs disappeared and anemia decreased. We also noticed a
sharp decrease in serum calcium and phosphate levels, and a slower
decrease in serum alkaline phosphatase. In the postoperative period, it
was often necessary to provide calcium and active vitamine D metabo-
lites. Preventative treatment was adopted and provided easy control of
calcemia and phosphoremia.
Iminunohistochemical study of the human glomerular C3b receptor.
M. D. Kazatchkine, D. T. Fearon, M. D. Appay, C. Mandet, and J.
Bariety. INSERM U-28, Hôpital Broussais, Paris, France, and R. B.
Brigham Hospital, Boston, Massachusetts. Receptors for C3b have
been demonstrated in normal glomeruli by the selective binding to
kidney sections of C3b-coated cells (EC3b). Decreased ability of
glomeruli to bind EC3b has been reported in glomerular diseases
associated with subepithelial and/or mesangial C3 deposition. The C3b
receptor of human erythrocytes, polymorphonuclear leucocytes, mono-
cytes, and B lymphocytes in a glycoprotein formed from a polypeptide
chain of Mr 205,000, gp205. We used a rabbit antibody to gp205 and
demonstrated the localization on the plasma membrane of normal
podocytes of the C3b receptor and evaluates the C3b receptor antigen
activity in diseased kidneys. In normal kidney specimens, podocytes of
all glomerular tufts that were examined were stained for anti-gp205. No
other cell was positive in the glomerulus or renal cortex. Using
immunoperoxidase and electronmicroscopy, a homogeneous granular
staining was seen on the cell coat of podocytes: main body, trabecules,
and pedicels. The reaction product was seen within some Golgi
apparatus, indicating a synthesis of the molecule by the podocyte.
Seventy-seven renal biopsies were examined by immunofluorescence.
A pattern similar to that of normal kidneys was seen in minimal
glomerular changes, membranous nephritis, membranoproliferative
glomerulonephritis type I, acute glomerulonephritis, toxemia of preg-
nancy, mesangial nephritis, Henoch-SchOlein purpura, and in extraglo-
merular diseases, for example, interstitial nephritis, nephroangiosclero-
sis, and renal transplants. In contrast, extracapillary proliferating cells
in RPGN, Wegener's granulomatosis, and Goodpasture's syndrome
were negative; there was no staining of hyaline zones and of podocytes
in early lesions of focal segmental hyalinoses. In SLE, decreased
staining was found in diffuse proliferative glomerulonephritis and did
not correlate with the localization or intensity of glomerular deposits.
Staining was not seen next to amyloid deposits and to Kimmelstiel
Wilson nodules. Obsolescent glomeruli were negative. The C3b recep-
tor is a specific marker of the podocyte; C3b receptor antigen activity is
not related to the presence of C3 and of immune glomerular deposits.
Measuring aluminum in bones by imnpulsional polarography. M.
Kessler, D. Burnel, M. E. Hutin, P. Netter, C. Huriet. Hôpital de
Brabois, Vandoeuvre, France. We proposed a method for measuring
aluminum in bone tissue which is safe, renewable, eliminates interac-
tions due to phosphate, and can be applied to samples obtained by bone
biopsy. In control subjects the level of aluminum in bone tissue
amounts to 18.8 ig per g of bone tissue 5.8 g per g. We did not find
any significant difference between trabecular and cortical bone tissue.
A correlation does not exist between age and the level of aluminum in
bone. In 8 patients suffering from chronic renal failure treated by
regular hemodialysis who were given aluminum hydroxide, the level
varies, but in 2 patients suffering from severe osteomalacia, significantly
higher levels of aluminum were found in bone tissue. Data in the
literature and our results indicate that the measurement of aluminum
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level in bone tissue is important. It would enable us to evaluate up to a
point the level of aluminum in the organism.
Phagocytic activity of monocytes in nonsystemic glomerulonephritis
(GN). G. LaGrue, A. Branellec, J. M. Heslan, A. Cattaneo, G. Hirbec,
and J. L. Ansquer. Hôpital Henri Mondor, Service de Néphrologie,
Créteil, France. Circulating immune complexes (CIC) account for a
majority of GN. Their pathogenicity depends on size and molecular
composition and on glomerular hemodynamics. Moreover, the activity
of phagocytes affects the rate of CIC removal. The phagocytic function
of peripheral monocytes was studied in 23 patients with nonsystemic
ON. All these patients with normal renal function or mild chronic renal
failure, with or without nephrotic syndrome, had a kidney biopsy
analyzed by light and fluorescence microscopy. Phagocytic activity of
peripheral blood monocytes was assessed in vitro, by calculating
phagocytic index (number of Zymozan particles in each monocyte) and
phagocytosis percentage (PP, the number of phagocyting monocytes);
the tests were camed Out on autologous and heterologous serum
samples. In 13 controls PP was 79 5.8%. In 7 membranous ON and 6
membranoproliferative GN, PP was severely decreased, 63.4 9.6%
and 52.1 18.8%. Similar findings were seen in 10 lipoid nephrosis, PP
= 52.2 14%. In each group of ON, these results were significantly
different from controls (P < 0.01). In all groups these results were
similar in autologous and heterologous serum samples (55 13% and
57.5 16% — NS). Therefore, this defect was not linked to the
presence of serum inhibitors. There was no correlation between alter-
ation of phagocytosis and the intensity of NS or the level of renal
failure. In conclusion, alterations of monocytic and phagocytic activity
is present in some primary ON; the significance of this abnormality is
unclear.
Serum IgE in glomerulonephritis (GN). G. LaGrue, J. Laurent, G.
Hirbec, J. C. Ansquer, C. Noirot, and D. Beighiti. Hôpital Henri
Mondor, Service de Nephrologie, Créteil, France. Among immunologi-
cal factors involved in ON, the role of allergy and IgE antibodies are
seldom discussed. Nonetheless, elevated serum IgE levels were earlier
found in lipoid nephrosis (NL). Some GN patients with simultaneous
atopic disorders were reported. We measured IgE by the RIST test in
181 subjects. A log expression allowed a Oaussian distribution in
controls: geometric mean value in 24 controls was 109 lU/mi with an
upper limit (mean + 2 SD) at 460 lU/mi. GN patients numbering 157
were classified according to light and immunofluorescence microscopy
and studied. As the distribution remained nonGaussian in some GN
groups, nonparametric statistical methods were used (Kruskall-Wallis
and Mann-Whitney tests). Serum IgE was significantly elevated in 39
NL patients (P < 0.001), 21 focal glomerulosclerosis (FGS) with (P <
0.05), and 42 membranous ON (MGN) with P < 0.01, in comparison
with controls. Oeometric means were 493, 297 and 230 LU/mI, respec-
tively. In contrast, 27 membranoproliferative GN and 28 IgA ON had
IgE values that were not different from controls (geo. mean: 158 and 129
lU/mI). In addition, the NL group was different from the MON group (P
<0.01) but not from the FGS. In NL patients significant abnormalities
(IgE >460 lU/mi) were present 21 times out of 39: This was reminiscent
of the high incidence of atopic disorders in NL. IgE greater than 460 IU/
ml was present 10 times out of 42 MON and 8 times out of 21 FSG. The
significance of elevated serum IgE is not clear. Release of vasoactive
mediators from IgE-sensitized mast cells or basophils could enhance
deposition of immune complexes or modify glomerular permeability,
especially in NL. IgE may also bind macrophages and subsequently
induce the release of enzymes and mediators.
Bone histopathology in dialysis encephalopathy (DE). G. Lancien, J. P.
Hervé, S. Pecker, and F. Cartier. Unite de Nephrologie, Hôpital
Pontchaillou, Rennes, France. In order to elucidate the nature and
course of the bone disease commonly associated with DE, 17 iliac,
crest-bone biopsies (ICBB) were performed in 13 DE patients on
dialysis for an average of 32 months (group 1), 18 ICBBs in 18 non-
encephalopathic patients on dialysis for an average of 27 months (group
2), and 34 ICBBs in 34 patients beginning dialysis therapy (group 3).
Osteomalacia was assessed histomorphometrically by percent osteoid
volume (OV) (normal < 6.5%) and hyperparathyroidism by osteoclast
resorption surface (ORS) (normal 3.6 1.1%). Mean OV was signifi-
cantly higher in group 1 (41 20%) than in group 2 (19 14%) or in
group 3(8 7.5%). Of the patients on dialysis for more than 2 years, the
1201 group 1 had a higher mean OV (49 17%) than the 12 of the group
2 (23 15%). In group 1, OV revealed a linear correlation with the
number of months with the beginning of dialysis. No such correlation
was seen in group 2. In group I the mean ORS was at the upper limit of
normal (4.8 6.9%), in group 2 it was 8.1 6.5%, and in group 39.6
8%. An ORS level over 10%, reflecting frank hyperparathyroidism, was
seen in only 2 patients of group 1, in 6 of group 2 and in 12 of group 3.
Thus, the duration of dialysis being equal, osteomalacia is more severe
among DE patients than among non-DE patients, and it follows an
evenly progressive course only in DE patients. This finding suggests an
etiologic factor common to all the DE patients in this center, possibly
dialysate aluminum. Moreover, hyperparathyroidism was too infre-
quent to be implicated in the pathogenesis of aluminum intoxication and
dialysis encephalopathy.
Influence of subtotal parathyroidectomy on anemia in chrome renal
failure. F. Maurice, M. David, and B. Guittienne. Maison de Sante
Médicale, Muihouse, France. Anemia certainly represents a frequent
and disabling consequence of chronic renal failure. Recent data have
revealed that in hemodialyzed patients, improvement of the anemia
occurs after subtotal parathyroidectomy. This effect is a result of either
a direct action of parathyroid hormone on erythropoiesis inhibition or
an indirect action on fibrosis of erythropoietical bone marrow. We
observed the evolution of hematocrit after parathyroidectomy in a
homogeneous group of 12 patients. These hemodialyzed patients had
the same dialysis strategy with a protein-rich diet and received no iron
therapy, hormones, or transfusions. For 6 of them, we noticed an
increase in hematocrit values. For the remaining 6, hematocrit was not
influenced significantly. The higher the improvement of anemia, the
higher was the severity of hyperparathyroidism. The initial level of
hematocrit had no predictive value. The improvement of this anemia in
the case of serious secondary hyperparathyroidism exhibited the impor-
tant part played by erythropoietic bone marrow fibrosis, but the anemia
reparation period after the fourth month was in favour of a toxic action
played by the parathyroid hormone.
Microscopic hematuria: renal or extrarenal? Phase contrast microsco-
py of urine sediment. H. Pellet, M. Thonnerieux, J. Depardon, and C.
Donne. Laboratoire d'Histologie-Embryologie U.E.R. Grange-Blanche
8, Lyon, France. Phase contrast microscopy provides a direct approach
in distinguishing between renal and extrarenal hematurias. In glomeru-
lar bleeding, hematic casts, if present, are easily observed, or a few
erythrocytes can be seen in the matrix of hyaline or granular casts.
These different types of casts would have probably been overlooked on
stained slides or in conventional light microscopy. We observed such
typical casts in less than half of the glomerular hematurias we studied.
In any case, when glomerular bleeding occurred, erythrocytes always
exhibited specific morphological changes, including a wide diversity of
shape and diameter, with an irregular outline and reduced hemoglobin
content. In extrarenal hematurias, the erythrocytes had a regular shape
and diameter, often revealing their usual biconcave aspect. Some had a
normal hemoglobin content, others had lost their hemoglobin (ghost
cells). Crenated cells were seen in both renal and extrarenal hematurias,
but they seemed more frequent when the bleeding had an extrarenal
origin. In renal but not glomerular hematurias, the erythrocytes were
more altered than in extrarenal hematurias, but their outline remained
regular and they were never inside casts. During the last 4 years, we
studied 10,000 urinary sediments. Our results have been corroborated
by other means of investigation, especially by renal biopsies. In isolated
hematurias, this simple and rapid investigation gave reliable indications
for appropriate future investigations.
Uremic polyneuropathy: A clinico-pathologic study. G. Said, L. Bou-
dier, J. Zingraff, and T. Drueke. Service de Neurologie, Hôpital de
Bicétre, Le Kremlin-Bicêtre and Department de Néphrologie, Hôpital
Necker, Paris, France. Five of 10 chronically uremic patients who were
treated by intermittent hemodialysis were observed for polyneuropathy
related to chronic renal failure (CRF). A quantitative study of myelinat-
ed fibers was done on sural nerve specimens taken by biopsy. Morpho-
logical studies included size-density distribution of myelinated fibers on
cross sections and teased nerve fiber preparations. Three patterns of
polyneuropathy were distinguished on the basis of clinical, electro-
physiological, and pathological findings. (1) Acute, sensorimotor poly-
neuropathy occurred after a sudden worsening of CRF in 4 patients.
Motor nerve conduction velocities (MNCV) were not measurable
because of complete denervation of distal muscles. Axonal degenera-
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tion was prominent on teased-fiber preparations. After treatment with
intermittent hemodialysis or renal transplantation, the patients revealed
a neurological condition that improved gradually over several months
but incompletely in some of them. (2) Progressive polyneuropathy was
exhibited in 4 patients under intermittent hemodialysis. In this group,
the sensonmotor deficit was less dramatic, but paresthesiae and neuro-
genic pains were more frequent. MNCV were low. Segmental demy-
elination and remyelination of single fibers were associated with
Wallerian degeneration and a loss of large myelinated fibers. Loss of
light touch sensation over a stocking distribution, the first sign of
peripheral neuropathy found on clinical examination, was consistent
with a dying-back degeneration of the longest and largest myelinated
axons. (3) Two patients with low MNCV but without clinical symptoms
exhibited only minor morphological changes consisting mainly of
paranodal demyelination of some Ranvier nodes in 4 to 5% of the single
fibers. Our study described that in the early stages of CFR, low MNCV
is not associated with severe morphological changes. The slowing of
MNCV may be due in part to alterations of the properties of the
membranes in the area of the nodes of Ranvier and perhaps to the
conduction block of some fibers. In patients who are thought not to be
dialyzed sufficiently, a degeneration of myelinated fibers, probably of
the dying-back type, is associated with segmental demyelination. A
sudden worsening of renal failure may induce an acute axonal polyneur-
opathy. In conclusion, morphological studies of sural nerve biopsy
specimens have been shown: (1) to characterize the type of neuropathy,
(2) to establish its prognosis, and (3) to allow readjustment of the
dialysis schedule when recent lesions could be demonstrated.
Polycythemia secondary to the secretion of extrarenal erythropoietin in
a hemodialyzed, anephric patient with hepatitis. P. Simon, G. Boffa, and
K. S. Ang. Service de Nephrologie, CH Saint-Brieuc, and Centre
National de Transfusion Sanguine, Paris, France. A 45-year-old wom-
an began hemodialysis in 1966, had a bilateral nephrectomy in 1967, a
splenectomy in 1975, and non-B hepatitis in 1978. She received the last
transfusion of packed-red blood cells 10 months before getting hepatitis.
Anemia was stabilized and hematocrit was 19%. The hemoglobin level
was 6.3 g/dl, and the reticulocyte count was 1.5%. Two months after the
initial stages of hepatitis, the SGOT was 105 lU/mi (NI < 20 lU/mi),
SGPT 125 lU/mI (NI < 25 lU/mI), gamma glutamyl transpeptidase(yGT) of 325 LU/mI (NI < 35 LU/mI). Hematocrit was 38%, and the
hemoglobin level 11.7 g/dl. Her reticulocyte count was 9.5%. Her
hematocrit and hemoglobin levels remained elevated from December
1978 to March 1980. Cytolysis and then cholestasis were present during
that same period. Plasma was first collected for the erythropoietin
measurement in March 1980. The erythropoietin value was 82 mU/mi
(normal values, 5 to 20 mU/mi). After March 1980, liver enzyme levels
slowly returned to normal. The hemoglobin level and hematocrit slowly
decreased and by May 1980 were respectively 10 g/dl and 29%. The
reticulocyte count was 2.5%. Second and third erythropoietin levels
were determined on May 21 and 23. The values were respectively 57
mU/ml and 36 mU/mi. By September 1980, while liver enzymes (SGOT,
SGVF) remained normal and yGT stayed moderately elevated, hemato-
crit decreased to 24% and the hemoglobin level to 7.5 g/dl. The
reticulocyte count was 2%. The erythropoietin level was determined
most recently on September 11 and was 24 mU/ml. Our observation
strongly suggests that (1) in the uremic patient who has had a bilateral
nephrectomy and splenectomy, regenerating hepatocytes after cytoly-
sis can regain some of their fetal capacity to secrete erythropoietin, and
(2) in at least some patients undergoing dialysis the response of uremic
bone marrow to erythropoietin is not impaired.
Acute renal failure due to ajmaline. F. Schillinger, J. Chanliau, R.
Montagnac, J. L. Pusquali, and H. Jahn. Services de Nephrologie et
d'Hemodialyse du CHG de Troyes et du CHU de Strasbourg, France.
We observed 3 cases of acute renal failure (ARF) that followed a low
dose of ajmaline in 34-, 48-, and 68-year-old women. In a period of 6
months, the first patient presented 2 episodes of anuria, linked each
time to a single dose of ajmaline, but only at the second episode was the
drug incriminated. The clinical picture is that of acute immunoallergic
tubular necrosis with fever, chills, headache, lumbar pain, gastrointesti-
nal dysfunction, and dark urine, immediately following drug absorption.
Transient hemolysis was proven in 2 cases but not in the third, probably
because of late hospitalization. Two patients had to be hemodialyzed;
all 3 regained normal renal function. Renal biopsies were performed on
the patients after a diuresis recovery in the 3 cases. They confirmed
tubulonephritis with strong interstitial reactions of the lymphocytes and
eosinophiles; there were no immune deposits. Besides hemolytic ane-
mia and thrombocytopenia in 2 cases, there were circulating immune
complexes in all 3. A lymphocyte transformation test with ajmaline was
positive in 1 case only, but antiajmaline antibodies were found in all 3
cases: In the presence of drug, polyvalent antiglobulin, and anticomple-
ment sera, there was hemolysis, both with autologous and with test
erythrocytes. Ajmaline causes immune, hemolytic anemia with ARF
because the negative reaction is due to a low dose of this drug in
previously sensitized patients. Chlorhydrate of ajmaline and chlorhy-
drate of chloroacetyl-ajmaline must be excluded in these patients to
avoid relapses. Our report emphasizes the importance of investigating
the possibility of drug hypersensitivity in all cases of unexplained ARF.
A study of dialysis. H. Thon That, P. Grimal, C. Goudable, P. Bones,
D. Durand, and J. M. Suc. Service de Néphrologie and Groupe
INSERM U-133, CHU Rangueil, Toulouse, France. Our cooperative
study involving 12 dialysis centers in the Midi-Pyrénées continued for
18 months, from 01/01/79 until 06/30/80. We observed 552 dialyzed
patients in order to consider the results of a previous regional plan for
dialysis. Based on our study, it has been established that during the next
5 years facilities for 50 new dialyzed patients per million inhabitants will
be required. Our study also indicated that: (1) Two hundred thirty-one
patients per million inhabitants are on dialysis. This ratio varies
according to "department," from 150 to 309 patients per million
inhabitants. The mean age is 52, with a definite trend toward an increase
in the number of elderly patients, when compared with previous years.
(2) The proportion of home-dialysis patients is 24%, of which 88% are
on hemodialysis and 12% on peritoneal dialysis. There has been a
clearcut rise in the proportion of CAPD in the last 2 years. (3)
Progressive development of private or public dialysis centers in most of
the "departments" in the region has reduced considerably the length of
travel for the patients (average 30.7 Km). (4) The most frequent causes
of CRF are chronic interstitial nephropathies (37.4%), followed by
chronic glomerulonephritis (21.6%), polycystic kidney disease (14%)
and vascular nephropathies. (5) A.V. fistula is the most common
vascular access (90.4%) with a mean life of 24 months. (6) The most
frequent complications, varying with the centers, are vascular (HBP
30.8%), coronary insufficiency (17%), cardiac failure (16.9%), frequen-
cy of viral hepatitis (7.3%), and pericarditis (4%). (7) Adaptation to
dialysis and rehabilitation are better in younger patients who had
previous experience with good, professional environments. Rehabilita-
tion is 72% successful for home dialysis patients and only 37%
successful in center dialysis patients.
Fatal paraquat poisoning: A case with acute renal failure and ultra-
structural kidney study. G. Touchard, 0. Pourrat, P. Babin, P. Nolen,
and D. Patte. Service de Reanimation and Nephrologie, Hôpital Jean
Bernard, Poitiers, France. A 65-year-old man was admitted to the
hospital after taking 6 g of Paraquat (P) in a suicide attempt. Therapy
included gastric lavage, activated charcoal, Fuller's earth, osmotic
diuresis, furosemide, pentoneal dialysis, and plasma exchanges. Plas-
maP level was 0.624 mg/i, that is, 5 times higher than the "lethal" level
according to Proudfoot; the plasma level fell to 0.230 mg/I after the third
plasma exchange. Sudden death occurred by irreversible asystolic
cardiac arrest. Biopsies of the kidney and lung were performed immedi-
ately following death. Light and electron microscopic studies of the
lung showed interstitial edema and hemorrhage as previously de-
scried. The kidney exhibited tubular cell lesions and necrosis, intersti-
tial edema, and capillary congestion. Ultrastructural studies found
normal basement membranes (BM) in tubular, interstitial, and glomeru-
lar capillaries. Interstitial capillaries presented a detachment of endo-
thelial cells from the BM; interstitium was edematous with numerous
deposits of fibrin, and tubular lesions were marked. Glomerular lesions
not previously described were noted: Detachment of epithelial, cell-foot
processes and, to a lesser degree, endothelial cells from the glomerular
BM were seen. The normal fibrils between epithelial, piasmic mem-
brane and glomerular BM were not found. Lysis of fibronectine by P is
suggested as the hypothesis to explain these lesions.
Recurrent nephrotic syndrome (NS), secondary to alclofenac adminis-
tration. P. Vereerstraeten, V. Thoua, L. Schandene, J.-L. Vanher-
weghem, and C. Toussaint. Cliniques Universitaires de Bruxelles,
Hôpital Erasme, Brussels, Belgium. In May 1980, a 56-year-old male
patient, having absorbed several analgesic and antiinflammatory drugs
during 30 years for sciaticalgia secondary affecting a ruptured interver-
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tebral disc, developed NS associated with moderate renal insufficiency
(RI). A percutaneous renal biopsy revealed only minimal lesions. NS
and RI resolved after one-month of diuretic therapy. In August 1980,
recurrence of pain led to oral administration of alclofenac and of
diclofenac. Fifteen days later, the NS flared up again with characteris-
tics similar to those observed in May. Eosinophilia reached 400/mm3
and IgA 588 mgldl. A second renal biopsy revealed a few lymphocytes
and plasma cell, interstitial infiltrates as well as the absence of Ig and C3
granular deposits with IF techniques. The lymphoblastic transformation
test (LiT) was positive for alclofenac. Blood and urine abnormalities
disappeared after 3 weeks of diuretic administration. The patient was
asymptomatic 3 months later. This case associated recurrent and
reversible NS with minimal, interstitial lesions possibly due to alclo-
fenac hypersensitivity, as suggested by LTF. Other antiinflammatory
drugs, chemically related to alclofenac were previously reported to be
responsible for similar lesions.
